1. |
|
2. |
|
3. |
|
4. |
Ren Z, Liu Y, Ma Y, et al. Treatment of articular cartilage defects: A descriptive analysis of clinical characteristics and global trends reported from 2001 to 2020. Cartilage, 2023.
|
5. |
|
6. |
|
7. |
|
8. |
|
9. |
|
10. |
|
11. |
|
12. |
|
13. |
|
14. |
|
15. |
|
16. |
Beer AJ, Tauro TM, Redondo ML, et al. Use of allografts in orthopaedic surgery: Safety, procurement, storage, and outcomes. Orthop J Sports Med, 2019, 7(12): 2325967119891435.
|
17. |
Weber AE, Locker PH, Mayer EN, et al. Clinical outcomes after microfracture of the knee: Midterm follow-up. Orthop J Sports Med, 2018, 6(2): 2325967117753572.
|
18. |
|
19. |
|
20. |
|
21. |
|
22. |
|
23. |
|
24. |
|
25. |
|
26. |
|
27. |
|
28. |
|
29. |
Mehta VM, Mehta S, Santoro S, et al. Short term clinical outcomes of a Prochondrix® thin laser-etched osteochondral allograft for the treatment of articular cartilage defects in the knee. J Orthop Surg (Hong Kong), 2022, 30(3): 10225536221141781.
|
30. |
|
31. |
|
32. |
|
33. |
|
34. |
|
35. |
Liang Y, Li J, Wang Y, et al. Platelet rich plasma in the repair of articular cartilage injury: A narrative review. Cartilage, 2022, 13(3): 19476035221118419.
|
36. |
Baird HBG, Ashy CC, Kodali P, et al. Most publications regarding platelet-rich plasma use in the knee are from Asia, investigate injection for osteoarthritis, and show outcome improvement: A scoping review. Arthroscopy, 2024.
|
37. |
Li M, Tu Y, Zhang H, et al. Effect of platelet-rich plasma scaffolding combined with osteochondral autograft transfer for full-thickness articular cartilage defects of the femoral condyle. Biomed Mater, 2022, 17(6).
|
38. |
|
39. |
|
40. |
|